The dynamic evolution of lineage switch under CD19 CAR-T treatment in non-KMT2A rearranged B-ALL patients

Related articles

1. Single-cell sequencing uncovers clonal dynamics profiles and therapeutic resistance biomarkers in relapsed and refractory peripheral T-cell lymphoma

   This article has 17 authors:

   1. Xianhuo Wang
   2. Ning Zhang
   3. Jingwei Yu
   4. Hengqi Liu
   5. Zechao Hu
   6. Shen Meng
   7. Cong Sun
   8. Yaxiao Lu
   9. Xia Liu
   10. Zheng Song
   11. Lanfang Li
   12. Lihua Qiu
   13. Zhengzi Qian
   14. Shiyong Shiyong Zhou
   15. Bin Meng
   16. Wenchen Gong
   17. Hui-Lai Zhang

2. AI-driven structural analysis clarifies novel TNFRSF17 variants of uncertain significance as drivers of resistance to BCMA-targeted immunotherapies in multiple myeloma

   This article has 19 authors:

   1. Ricardo Kosch
   2. Behnam Yousefi
   3. Nora Constanze Laubach
   4. Marietta Truger
   5. Torsten Haferlach
   6. Sven Heins
   7. Raphael Teipel
   8. Piet Sonnemann
   9. Maximilian Al-Bazaz
   10. Jule Artzenroth
   11. Lisa Leypoldt
   12. Christoph Schaefers
   13. Maximilian Christopeit
   14. Moritz Kaune
   15. Leo Rasche
   16. Carsten Bokemeyer
   17. Katja Weisel
   18. Stefan Bonn
   19. Winfried Alsdorf

3. Low-dose CD7 chimeric antigen receptor T cells for relapsed/refractory T-cell lymphomas: single-arm, open-label, phase I study

   This article has 13 authors:

   1. Kai Hu
   2. Fan Yang
   3. Rui Liu
   4. Zhonghua Fu
   5. Yuelu Guo
   6. Lixia Ma
   7. Miaomiao Cao
   8. Biping Deng
   9. Alex H. Chang
   10. Haifeng Wu
   11. Shilin Gan
   12. Chen Chen
   13. Xiaoyan Ke